SARS-CoV-2 infection in an advanced rheumatoid arthritis patient Dear Editor, In late 2019, pneumonia due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, which has immediately spread around the world. The major clinical manifestations of COVID-19 include a range from asymptomatic presentation to acute respiratory distress syndrome (ARDS) (1). Rheumatoid arthritis (RA) patients usually manage with immunosuppressive agents; hence, they are at a higher risk of infections (2). However, limited data are available about the severe case of COVID-19 in RA patients (3-7). Here, we present a complicated case of SARS-CoV-2 infection in a female RA patient.

Rheumatoid Arthritis (RA) patients usually managed with immunosuppressive agents and they are at a higher risk of infections. There are limited data regarding RA patients with COVID-19. This article reports a RA patient with an acute SARS‐CoV‐2 infection that successfully managed by dose reduction of immunosuppressive medication.

Abstract Rheumatoid Arthritis (RA) patients usually managed with immunosuppressive agents and they are at a higher risk of infections. There are limited data regarding RA patients with COVID-19. This article reports a RA patient with an acute SARS‐CoV‐2 infection that successfully managed by dose reduction of immunosuppressive medication.